Medicines labeled for the same conditions
Alternatives to vericiguat
16 other medicines are given the same way (oral) and in the same FDA class as vericiguat or labeled mainly for the same use (heart failure); the others include 3 aldosterone antagonists, 2 thiazide diuretics and 2 loop diuretics (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as vericiguat?
Heart failure lists all 37 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Vericiguatsoluble guanylate cyclase stimulator | this medicine | none listed | $22.72 per tablet 10 mg tablet | Yes | No current entry |
| Carvedilolalpha-adrenergic blocker | Heart failure | 41 labelers | $0.0179 per tablet 6.25 mg tablet | No | No current entry |
| Spironolactonealdosterone antagonist | Heart failure | 38 labelers | $0.0426 per tablet 25 mg tablet | No | A presentation being discontinued |
| Hydrochlorothiazidethiazide diuretic | Heart failure | 44 labelers | $0.0115 per tablet 25 mg tablet | No | A presentation being discontinued |
| Furosemideloop diuretic | Heart failure | 33 labelers | $0.026 per tablet 20 mg tablet | No | In shortage |
| Sacubitril and valsartanneprilysin inhibitor | Heart failure | 27 labelers | $0.533 per unit 49-51 mg | Yes | No current entry |
| Bumetanideloop diuretic | Heart failure | 24 labelers | $0.108 per tablet 1 mg tablet | Yes | Resolved |
| Digoxincardiac glycoside | Heart failure | 21 labelers | $0.133 per tablet 125 mcg tablet | No | No current entry |
| Ivabradinehyperpolarization-activated cyclic nucleotide-gated channel blocker | Heart failure | 11 labelers | $0.761 per tablet 5 mg tablet | No | A presentation being discontinued |
| Eplerenonealdosterone antagonist | Heart failure | 9 labelers | $0.308 per tablet 25 mg tablet | No | No current entry |
| Hydrochlorothiazide and spironolactonealdosterone antagonist | Heart failure | 6 labelers | $0.483 per tablet 25-25 tablet | No | No current entry |
| Empagliflozinsodium-glucose cotransporter 2 inhibitor | Heart failure | none listed | $11.19 per tablet 10 mg tablet | No | No current entry |
| Triamterenepotassium-sparing diuretic | Heart failure | 3 labelers | $5.98 per capsule 50 mg capsule | Yes | No current entry |
| Hydralazine and isosorbide dinitratearteriolar vasodilator | Heart failure | 3 labelers | $0.714 per tablet 20-37.5 mg tablet | No | No current entry |
| Sotagliflozinsodium-glucose cotransporter 2 inhibitor | Heart failure | none listed | $20.37 per tablet 200 mg tablet | No | No current entry |
| Amiloride and hydrochlorothiazidepotassium-sparing diuretic | Heart failure | 1 labeler | $0.450 per tablet 5-50 mg tablet | Yes | No current entry |
| Chlorothiazidethiazide diuretic | Heart failure | none listed | n/a | No | A presentation being discontinued |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Vericiguat: the full record
- label, generics, price, shortages, recalls